Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance.
Mycoplasma genitalium (Mg) causes symptomatic urethritis in men, and can infect alone or together with other STI agents. The prevalence of Mg and other STIs were determined in 1816 men with symptomatic urethritis. Resistance of Mg to macrolides and fluoroquinolones was determined by sequencing; the impact of recent antimicrobial usage on the distribution of Mg single or mixed infections was determined. Overall, prevalence of Mg infection was 19.7% (358/1816). 54.1% (166/307) of Mg infections occurred alone in the absence of other STI agents. Men with single Mg infection self-administered or were prescribed antibiotics more often in the 30 days prior to enrollment than subjects with urethritis caused by Mg coinfection (P<0.0001). Higher rates (96.7%) of infection with macrolide resistance in Mg were identified in men who had taken macrolides prior to enrollment (P< 0.03). Overall, 88.9% (303/341) of 23S rRNA genes contained mutations responsible for macrolide resistance; 89.5% (308/344) of parC and 12.4% (42/339) of gyrA genes had mutations responsible for fluoroquinolone resistance. 87.7% (270/308) of Mg had combined mutations in 23S rRNA and parC genes; 10.4% (32/308) had mutations in all three genes. Mg was the single pathogen identified in 11% of men with symptomatic urethritis. Overall, nearly 90% of Mg were resistant to macrolides and fluoroquinolones. Men who took macrolides in the 30 days prior to enrollment had higher rates (97%) of macrolide resistant Mg. Resistance was associated with numerous mutations in 23SrRNA, parC and gyrA genes.